Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    CONE-ROD DYSTROPHY 1
Show Display Options
Rank Status Study
1 Recruiting NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
Condition: Foot Ulcer, Diabetic
Interventions: Other: NEOX® CORD 1K;   Procedure: Standard of Care (Pressure Bandage)
2 Recruiting Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy
Conditions: Retinitis Pigmentosa,;   Cone Rod Dystrophy,;   Choroideremia
Intervention: Device: Intelligent Retinal Implant System
3 Recruiting Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B
Conditions: Usher Syndrome;   Retinitis Pigmentosa
Intervention: Genetic: UshStat
4 Completed Study of Usher Syndromes, Type 1 and Type 2
Condition: Retinitis Pigmentosa
Intervention:
5 Completed Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: intravitreal injection of autologous bone marrow stem cells
6 Enrolling by invitation A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of UshStat® in Patients With Usher Syndrome Type 1B
Condition: Usher Syndrome Type 1b
Intervention: Drug: UshStat
7 Completed Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Conditions: LCA (Leber Congenital Amaurosis);   RP (Retinitis Pigmentosa)
Intervention: Drug: QLT091001
8 Active, not recruiting Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)
Condition: Retinitis Pigmentosa (RP)
Intervention: Drug: QLT091001
9 Recruiting Repository for Inherited Eye Diseases
Conditions: Retinitis Pigmentosa;   Inherited Ophthalmic Diseases
Intervention:
10 Completed Microcurrent Stimulation to Treat Macular Degeneration
Conditions: Retinal Diseases;   Stargardt's Disease;   Retinitis Pigmentosa
Intervention:
11 Recruiting Gene Therapy for Blindness Caused by Choroideremia
Condition: Choroideremia
Intervention: Drug: rAAV2.REP1

Indicates status has not been verified in more than two years